Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 331

1.

An abnormal capnography trace due to air embolism in the lateral position.

Lee YL, Hwang KY, Yew WS, Ng SY.

BMJ Case Rep. 2019 Aug 28;12(8). pii: e231316. doi: 10.1136/bcr-2019-231316.

PMID:
31466962
2.

Does oxidative stress contribute to antituberculosis drug resistance?

Yew WW, Chan DP, Chang KC, Zhang Y.

J Thorac Dis. 2019 Jul;11(7):E100-E102. doi: 10.21037/jtd.2019.06.36. No abstract available.

3.

Author Correction: Building a global alliance of biofoundries.

Hillson N, Caddick M, Cai Y, Carrasco JA, Chang MW, Curach NC, Bell DJ, Feuvre RL, Friedman DC, Fu X, Gold ND, Herrgård MJ, Holowko MB, Johnson JR, Johnson RA, Keasling JD, Kitney RI, Kondo A, Liu C, Martin VJJ, Menolascina F, Ogino C, Patron NJ, Pavan M, Poh CL, Pretorius IS, Rosser SJ, Scrutton NS, Storch M, Tekotte H, Travnik E, Vickers CE, Yew WS, Yuan Y, Zhao H, Freemont PS.

Nat Commun. 2019 Jul 11;10(1):3132. doi: 10.1038/s41467-019-10862-1.

4.

Does linezolid have a role in shortening treatment of tuberculosis?

Yew WW, Chan DP, Chang KC.

Clin Microbiol Infect. 2019 Sep;25(9):1060-1062. doi: 10.1016/j.cmi.2019.06.020. Epub 2019 Jun 22. No abstract available.

PMID:
31238119
5.

Can vitamin C help in managing tuberculosis associated with diabetes mellitus?

Yew WW, Chang KC, Chan DP, Zhang Y.

Respirology. 2019 Aug;24(8):819-820. doi: 10.1111/resp.13579. Epub 2019 May 20. No abstract available.

6.

Building a global alliance of biofoundries.

Hillson N, Caddick M, Cai Y, Carrasco JA, Chang MW, Curach NC, Bell DJ, Le Feuvre R, Friedman DC, Fu X, Gold ND, Herrgård MJ, Holowko MB, Johnson JR, Johnson RA, Keasling JD, Kitney RI, Kondo A, Liu C, Martin VJJ, Menolascina F, Ogino C, Patron NJ, Pavan M, Poh CL, Pretorius IS, Rosser SJ, Scrutton NS, Storch M, Tekotte H, Travnik E, Vickers CE, Yew WS, Yuan Y, Zhao H, Freemont PS.

Nat Commun. 2019 May 9;10(1):2040. doi: 10.1038/s41467-019-10079-2. No abstract available. Erratum in: Nat Commun. 2019 Jul 11;10(1):3132.

7.

Metformin as a host-directed therapeutic in tuberculosis: Is there a promise?

Yew WW, Chang KC, Chan DP, Zhang Y.

Tuberculosis (Edinb). 2019 Mar;115:76-80. doi: 10.1016/j.tube.2019.02.004. Epub 2019 Feb 13. Review.

PMID:
30948180
8.

Mathematical modelling of the impact of treating latent tuberculosis infection in the elderly in a city with intermediate tuberculosis burden.

Chong KC, Leung CC, Yew WW, Zee BCY, Tam GCH, Wang MH, Jia KM, Chung PH, Lau SYF, Han X, Yeoh EK.

Sci Rep. 2019 Mar 19;9(1):4869. doi: 10.1038/s41598-019-41256-4.

9.

Rapid assessment of total MCPD esters in palm-based cooking oil using ATR-FTIR application and chemometric analysis.

Goh KM, Maulidiani M, Rudiyanto R, Wong YH, Ang MY, Yew WM, Abas F, Lai OM, Wang Y, Tan CP.

Talanta. 2019 Jun 1;198:215-223. doi: 10.1016/j.talanta.2019.01.111. Epub 2019 Jan 31.

PMID:
30876552
10.

Can treatment outcomes of latent TB infection and TB in silicosis be improved?

Yew WW, Leung CC, Chang KC, Zhang Y, Chan DP.

J Thorac Dis. 2019 Jan;11(1):E8-E10. doi: 10.21037/jtd.2018.12.113. No abstract available.

11.

Early treatment with minocycline following stroke in rats improves functional recovery and differentially modifies responses of peri-infarct microglia and astrocytes.

Yew WP, Djukic ND, Jayaseelan JSP, Walker FR, Roos KAA, Chataway TK, Muyderman H, Sims NR.

J Neuroinflammation. 2019 Jan 9;16(1):6. doi: 10.1186/s12974-018-1379-y.

12.

Innovative autocrats? Environmental innovation in public participation in China and Malaysia.

Yew WL, Zhu Z.

J Environ Manage. 2019 Mar 15;234:28-35. doi: 10.1016/j.jenvman.2018.12.081. Epub 2018 Dec 29.

PMID:
30599327
13.

Detection of novel mutations associated with independent resistance and cross-resistance to isoniazid and prothionamide in Mycobacterium tuberculosis clinical isolates.

Islam MM, Tan Y, Hameed HMA, Liu Z, Chhotaray C, Liu Y, Lu Z, Cai X, Tang Y, Gao Y, Surineni G, Li X, Tan S, Guo L, Cai X, Yew WW, Liu J, Zhong N, Zhang T.

Clin Microbiol Infect. 2019 Aug;25(8):1041.e1-1041.e7. doi: 10.1016/j.cmi.2018.12.008. Epub 2018 Dec 22.

PMID:
30583053
14.

Management of adverse reactions to high-dose moxifloxacin used in multidrug-resistant tuberculosis treatment programmes.

Yew WW, Chang KC.

Respirology. 2019 Mar;24(3):201-203. doi: 10.1111/resp.13452. Epub 2018 Dec 6. No abstract available.

15.

Can modulating redox status help to enhance antituberculosis drug efficacy?

Yew WW, Chang KC, Chan DP, Zhang Y.

Tuberculosis (Edinb). 2018 Dec;113:177-178. doi: 10.1016/j.tube.2018.10.002. Epub 2018 Oct 9. No abstract available.

PMID:
30514500
16.

Vitamin C and Mycobacterium tuberculosis Persisters.

Yew WW, Chang KC, Leung CC, Chan DP, Zhang Y.

Antimicrob Agents Chemother. 2018 Oct 24;62(11). pii: e01641-18. doi: 10.1128/AAC.01641-18. Print 2018 Nov. No abstract available.

17.

Synthetic Enzymology and the Fountain of Youth: Repurposing Biology for Longevity.

Lim YP, Go MK, Raida M, Inoue T, Wenk MR, Keasling JD, Chang MW, Yew WS.

ACS Omega. 2018 Sep 30;3(9):11050-11061. doi: 10.1021/acsomega.8b01620. Epub 2018 Sep 12.

18.

Erratum for Yew et al., "Oxidative Stress and First-Line Antituberculosis Drug-Induced Hepatotoxicity".

Yew WW, Chang KC, Chan DP.

Antimicrob Agents Chemother. 2018 Sep 24;62(10). pii: e01633-18. doi: 10.1128/AAC.01633-18. Print 2018 Oct. No abstract available.

19.

Mutational Mtc6p attenuates autophagy and improves secretory expression of heterologous proteins in Kluyveromyces marxianus.

Liu Y, Mo WJ, Shi TF, Wang MZ, Zhou JG, Yu Y, Yew WS, Lu H.

Microb Cell Fact. 2018 Sep 14;17(1):144. doi: 10.1186/s12934-018-0993-9.

20.

Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis.

Collaborative Group for the Meta-Analysis of Individual Patient Data in MDR-TB treatment–2017, Ahmad N, Ahuja SD, Akkerman OW, Alffenaar JC, Anderson LF, Baghaei P, Bang D, Barry PM, Bastos ML, Behera D, Benedetti A, Bisson GP, Boeree MJ, Bonnet M, Brode SK, Brust JCM, Cai Y, Caumes E, Cegielski JP, Centis R, Chan PC, Chan ED, Chang KC, Charles M, Cirule A, Dalcolmo MP, D'Ambrosio L, de Vries G, Dheda K, Esmail A, Flood J, Fox GJ, Fréchet-Jachym M, Fregona G, Gayoso R, Gegia M, Gler MT, Gu S, Guglielmetti L, Holtz TH, Hughes J, Isaakidis P, Jarlsberg L, Kempker RR, Keshavjee S, Khan FA, Kipiani M, Koenig SP, Koh WJ, Kritski A, Kuksa L, Kvasnovsky CL, Kwak N, Lan Z, Lange C, Laniado-Laborín R, Lee M, Leimane V, Leung CC, Leung EC, Li PZ, Lowenthal P, Maciel EL, Marks SM, Mase S, Mbuagbaw L, Migliori GB, Milanov V, Miller AC, Mitnick CD, Modongo C, Mohr E, Monedero I, Nahid P, Ndjeka N, O'Donnell MR, Padayatchi N, Palmero D, Pape JW, Podewils LJ, Reynolds I, Riekstina V, Robert J, Rodriguez M, Seaworth B, Seung KJ, Schnippel K, Shim TS, Singla R, Smith SE, Sotgiu G, Sukhbaatar G, Tabarsi P, Tiberi S, Trajman A, Trieu L, Udwadia ZF, van der Werf TS, Veziris N, Viiklepp P, Vilbrun SC, Walsh K, Westenhouse J, Yew WW, Yim JJ, Zetola NM, Zignol M, Menzies D.

Lancet. 2018 Sep 8;392(10150):821-834. doi: 10.1016/S0140-6736(18)31644-1. Review.

21.

Immunomodulation as Therapy for Fungal Infection: Are We Closer?

Sam QH, Yew WS, Seneviratne CJ, Chang MW, Chai LYA.

Front Microbiol. 2018 Jul 25;9:1612. doi: 10.3389/fmicb.2018.01612. eCollection 2018. Review.

22.

Targeted Approaches for In Situ Gut Microbiome Manipulation.

Lee HL, Shen H, Hwang IY, Ling H, Yew WS, Lee YS, Chang MW.

Genes (Basel). 2018 Jul 12;9(7). pii: E351. doi: 10.3390/genes9070351. Review.

23.

Mutation EthAW21R confers co-resistance to prothionamide and ethionamide in both Mycobacterium bovis BCG and Mycobacterium tuberculosis H37Rv.

Mugweru J, Liu J, Makafe G, Chiwala G, Wang B, Wang C, Li X, Tan Y, Yew WW, Tan S, Zhang T.

Infect Drug Resist. 2018 Jun 13;11:891-894. doi: 10.2147/IDR.S163965. eCollection 2018.

24.

Oxidative Stress and First-Line Antituberculosis Drug-Induced Hepatotoxicity.

Yew WW, Chang KC, Chan DP.

Antimicrob Agents Chemother. 2018 Jul 27;62(8). pii: e02637-17. doi: 10.1128/AAC.02637-17. Print 2018 Aug. Review. Erratum in: Antimicrob Agents Chemother. 2018 Sep 24;62(10):.

25.

Molecular Targets Related Drug Resistance Mechanisms in MDR-, XDR-, and TDR-Mycobacterium tuberculosis Strains.

Hameed HMA, Islam MM, Chhotaray C, Wang C, Liu Y, Tan Y, Li X, Tan S, Delorme V, Yew WW, Liu J, Zhang T.

Front Cell Infect Microbiol. 2018 Apr 10;8:114. doi: 10.3389/fcimb.2018.00114. eCollection 2018. Review.

26.

Engineering microbes for targeted strikes against human pathogens.

Hwang IY, Lee HL, Huang JG, Lim YY, Yew WS, Lee YS, Chang MW.

Cell Mol Life Sci. 2018 Aug;75(15):2719-2733. doi: 10.1007/s00018-018-2827-7. Epub 2018 May 7. Review.

PMID:
29736607
27.

Reprogramming Probiotic Lactobacillus reuteri as a Biosensor for Staphylococcus aureus Derived AIP-I Detection.

Lubkowicz D, Ho CL, Hwang IY, Yew WS, Lee YS, Chang MW.

ACS Synth Biol. 2018 May 18;7(5):1229-1237. doi: 10.1021/acssynbio.8b00063. Epub 2018 Apr 13.

PMID:
29652493
28.

Early experience with delamanid-containing regimens in the treatment of complicated multidrug-resistant tuberculosis in Hong Kong.

Chang KC, Leung EC, Law WS, Leung WM, Tai LB, Lee SN, Lam FM, Chau CH, Mok TY, Yew WW, Leung CC.

Eur Respir J. 2018 Jun 14;51(6). pii: 1800159. doi: 10.1183/13993003.00159-2018. Print 2018 Jun. No abstract available.

PMID:
29650556
29.

Epidemiological, clinical and mechanistic perspectives of tuberculosis in older people.

Yew WW, Yoshiyama T, Leung CC, Chan DP.

Respirology. 2018 Jun;23(6):567-575. doi: 10.1111/resp.13303. Epub 2018 Apr 1. Review.

30.

RE: "DIETARY INTAKE OF ANTIOXIDANT VITAMINS AND CAROTENOIDS AND RISK OF DEVELOPING ACTIVE TUBERCULOSIS IN A PROSPECTIVE POPULATION-BASED COHORT".

Yew WW, Chan DP, Leung CC, Zhang Y.

Am J Epidemiol. 2018 Jul 1;187(7):1570-1571. doi: 10.1093/aje/kwx381. No abstract available.

PMID:
29370338
31.

Does oxidative stress contribute to adverse outcomes in HIV-associated TB?

Yew WW, Chan DP, Singhal A, Zhang Y, Lee SS.

J Antimicrob Chemother. 2018 May 1;73(5):1117-1120. doi: 10.1093/jac/dkx509.

PMID:
29325139
32.

Engineered commensal microbes for diet-mediated colorectal-cancer chemoprevention.

Ho CL, Tan HQ, Chua KJ, Kang A, Lim KH, Ling KL, Yew WS, Lee YS, Thiery JP, Chang MW.

Nat Biomed Eng. 2018 Jan;2(1):27-37. doi: 10.1038/s41551-017-0181-y. Epub 2018 Jan 10.

PMID:
31015663
33.

Pyrazinamide Is a Two-Edged Sword: Do WHO Guidelines Matter?

Chang KC, Yew WW, Zhang Y.

Antimicrob Agents Chemother. 2017 Dec 21;62(1). pii: e01907-17. doi: 10.1128/AAC.01907-17. Print 2018 Jan. No abstract available.

34.

Supramolecular strategy for reducing the cardiotoxicity of bedaquiline without compromising its antimycobacterial efficacy.

Kuok KI, In Ng PC, Ji X, Wang C, Yew WW, Chan DPC, Zheng J, Lee SMY, Wang R.

Food Chem Toxicol. 2018 Sep;119:425-429. doi: 10.1016/j.fct.2017.12.022. Epub 2017 Dec 16.

PMID:
29258954
36.

Molecular mechanisms of clofazimine resistance in Mycobacterium tuberculosis.

Yew WW, Liang D, Chan DP, Shi W, Zhang Y.

J Antimicrob Chemother. 2017 Oct 1;72(10):2943-2944. doi: 10.1093/jac/dkx227. No abstract available.

PMID:
29091204
37.

Engineering a riboswitch-based genetic platform for the self-directed evolution of acid-tolerant phenotypes.

Pham HL, Wong A, Chua N, Teo WS, Yew WS, Chang MW.

Nat Commun. 2017 Sep 4;8(1):411. doi: 10.1038/s41467-017-00511-w.

38.

Life-threatening Bleed Secondary to Tumor Shrinkage Effectively Palliated with Radiotherapy.

Tseng M, Yew W, Jeyasekharan A, Vellayappan B.

Cureus. 2017 Jun 24;9(6):e1386. doi: 10.7759/cureus.1386.

39.

Can toxicities induced by antituberculosis drugs be better managed in diabetic patients?

Yew WW, Chan DP, Leung CC, Zhang Y, Wang R, Ng P, Lee SM.

Eur Respir J. 2017 Jul 20;50(1). pii: 1700409. doi: 10.1183/13993003.00409-2017. Print 2017 Jul. No abstract available.

40.

Nontuberculous Mycobacteria Infections at a Provincial Reference Hospital, Cambodia.

Bonnet M, San KC, Pho Y, Sok C, Dousset JP, Brant W, Hurtado N, Eam KK, Ardizzoni E, Heng S, Godreuil S, Yew WW, Hewison C.

Emerg Infect Dis. 2017 Jul;23(7):1139-1147. doi: 10.3201/eid2307.170060.

41.

Pyrazinoic Acid Inhibits a Bifunctional Enzyme in Mycobacterium tuberculosis.

Njire M, Wang N, Wang B, Tan Y, Cai X, Liu Y, Mugweru J, Guo J, Hameed HMA, Tan S, Liu J, Yew WW, Nuermberger E, Lamichhane G, Liu J, Zhang T.

Antimicrob Agents Chemother. 2017 Jun 27;61(7). pii: e00070-17. doi: 10.1128/AAC.00070-17. Print 2017 Jul.

42.

Effects of diabetes mellitus on the clinical presentation and treatment response in tuberculosis.

Leung CC, Yew WW, Mok TYW, Lau KS, Wong CF, Chau CH, Chan CK, Chang KC, Tam G, Tam CM.

Respirology. 2017 Aug;22(6):1225-1232. doi: 10.1111/resp.13017. Epub 2017 Feb 28.

PMID:
28244689
43.

Oxidative stress and TB outcomes in patients with diabetes mellitus?

Yew WW, Leung CC, Zhang Y.

J Antimicrob Chemother. 2017 Jun 1;72(6):1552-1555. doi: 10.1093/jac/dkx046.

PMID:
28204508
44.

Drug resistance mechanisms and novel drug targets for tuberculosis therapy.

Islam MM, Hameed HMA, Mugweru J, Chhotaray C, Wang C, Tan Y, Liu J, Li X, Tan S, Ojima I, Yew WW, Nuermberger E, Lamichhane G, Zhang T.

J Genet Genomics. 2017 Jan 20;44(1):21-37. doi: 10.1016/j.jgg.2016.10.002. Epub 2016 Oct 11. Review.

PMID:
28117224
45.

Reactive astrogliosis in stroke: Contributions of astrocytes to recovery of neurological function.

Sims NR, Yew WP.

Neurochem Int. 2017 Jul;107:88-103. doi: 10.1016/j.neuint.2016.12.016. Epub 2017 Jan 3. Review.

PMID:
28057555
46.

Reprogrammable microbial cell-based therapeutics against antibiotic-resistant bacteria.

Hwang IY, Koh E, Kim HR, Yew WS, Chang MW.

Drug Resist Updat. 2016 Jul;27:59-71. doi: 10.1016/j.drup.2016.06.002. Epub 2016 Jun 22. Review.

PMID:
27449598
47.

Complexation of clofazimine by macrocyclic cucurbit[7]uril reduced its cardiotoxicity without affecting the antimycobacterial efficacy.

Li S, Chan JY, Li Y, Bardelang D, Zheng J, Yew WW, Chan DP, Lee SM, Wang R.

Org Biomol Chem. 2016 Aug 21;14(31):7563-9. doi: 10.1039/c6ob01060a. Epub 2016 Jul 21.

PMID:
27439674
48.

Exploiting the Biosynthetic Potential of Type III Polyketide Synthases.

Lim YP, Go MK, Yew WS.

Molecules. 2016 Jun 22;21(6). pii: E806. doi: 10.3390/molecules21060806. Review.

49.

Negligible risk of inducing resistance in Mycobacterium tuberculosis with single-dose rifampicin as post-exposure prophylaxis for leprosy.

Mieras L, Anthony R, van Brakel W, Bratschi MW, van den Broek J, Cambau E, Cavaliero A, Kasang C, Perera G, Reichman L, Richardus JH, Saunderson P, Steinmann P, Yew WW.

Infect Dis Poverty. 2016 Jun 8;5(1):46. doi: 10.1186/s40249-016-0140-y. Review.

50.

Suprascapular nerve injury: A cause to consider in shoulder pain and dysfunction.

Yao K, Yew WP.

J Back Musculoskelet Rehabil. 2016 May 13. [Epub ahead of print]

PMID:
27197708

Supplemental Content

Support Center